Merck & Co., Inc. — Director's Dealing 2023

Feb 16, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2023-02-15

Reporting Person: Romanelli Joseph (President, Human Health Int?l)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-02-15	Common Stock	S	5000	$108.2201	Disposed	20284.325	Direct